La chaîne d'options affiche les données clés des options sur actions de Regional Health Props à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Regional Health Props..

Regional Health Props (AMEX:RHE) Stock, Chaîne d'Options

Regional Health Props

Regional Health Properties Inc is a self-managed healthcare real estate investment company that invests in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transactions. It has two reportable segments real estate segment and the healthcare services segment. It derives the majority of its revenue from the healthcare services segment. Its portfolio of properties is diversified across various states, with concentrations in Georgia and Ohio.

Regional Health Properties, Inc. Common Stock

Regional Health Properties Inc

REGIONAL HLTH PPTY B PFD by Regional Health Properties, Inc.

Regional Health Properties, Inc. 10.875% Series A Cumulative Redeemable Preferred Stock

Rheinmetall AG

RHEINMETALL AG UNSP/ADR by Rheinmetall AG

RHEON AUTO MACHINE CO LTD by Rheon Automatic Machinery Co Ltd.

Rheon Automatic Machinery Co Ltd

<a href="https://www.bloomberg.com/news/articles/2025-01-08/biden-to-further-limit-nvidia-amd-ai-chip-exports-in-final-push?srnd=homepage-americas&amp;sref=TBDibEcD" title="https://www.bloomberg.com/news/articles/2025-01-08/biden-to-further-limit-nvidia-amd-ai-chip-exports-in-final-push?srnd=homepage-americas&amp;sref=TBDibEcD">https://www.bloomberg.com/news/articles/2025-01-08/biden-to-further-limit-nvidia-amd-ai-chip-exports-in-final-push?srnd=homepage-americas&amp;sref=TBDibEcD</a>

Macro Economic Events

News

Economics

NVDA

Bloomberg: Biden to Further Limit Nvidia, AMD AI Chip Exports in Final Push

Needham analyst Ryan MacDonald downgrades Accolade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>) from Buy to Hold.

Downgrades

Analyst Ratings

ACCD

Needham Downgrades Accolade to Hold

Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) has outperformed the market over the past 5 years by 23.43% on an annualized basis producing an average annual return of 35.91%. Currently, Dell Technologies has a market capitalization of $83.57 billion. 
Buying $1000 In DELL: If an investor had bought $1000 of DELL stock 5 years ago, it would be worth $4,733.10 today based on a price of $119.31 for DELL at the time of writing.
<h3>Dell Technologies's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736372710_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

DELL

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

D. Boral Capital analyst Jesse Sobelson maintains New Horizon Aircraft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOVR#NASDAQ">HOVR</a>) with a Buy and maintains $2 price target.

Price Target

HOVR

D. Boral Capital Maintains Buy on New Horizon Aircraft, Maintains $2 Price Target

Penguin Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PENG#NASDAQ">PENG</a>) reported its first-quarter financial results after Wednesday's closing bell. Here's a look at the <a href="https://www.benzinga.com/pressreleases/25/01/b42886023/penguin-solutions-reports-q1-fiscal-2025-financial-results">details from the report.&nbsp;</a>
The Details:&nbsp;Penguin Solutions reported quarterly earnings of 49 cents per share, which beat the analyst consensus estimate of 39 cents. Quarterly revenue came in at $341.1 million, beating the analyst consensus estimate of $320.75 million and representing an increase over sales of $274.25 million from the same period last year.
Read Next: <a href="https://www.benzinga.com/25/01/42878466/wildfire-rips-through-las-pacific-palisades-neighborhood-3000-acres-burned-30000-evacuated-homes-destroyed">Wildfire Rips Through LA&#8217;s Pacific Palisades Neighborhood Destroying Homes: 3,000 Acres Burned As 30,000 Residents Evacuate&nbsp;</a>
&#8220;Our strong performance this quarter, highlighted by a 49% year-over-year increase in Advanced Computing revenue, reflects the continued execution of our strategy to support customers navigating the complexities of AI infrastructure implementation,&#8221; said Mark Adams, CEO of Penguin Solutions. 
&#8220;Our approach as a provider of differentiated hardware, software and managed services enables us to serve as a trusted advisor for our large enterprise customers. Based on our positive start to the year, we are pleased to affirm our outlook for the full fiscal year,&#8221; concluded Adams.
Outlook: Penguin Solutions affirmed its fiscal 2025 outlook of earnings of between $1.30 and $1.70 per share and net sales growth of 15% year-over-year, plus or minus 5%.
PENG Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Penguin Solutions shares are up 14.48% after hours at $21.50 Wednesday.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/01/42854890/us-records-first-human-bird-flu-death-high-levels-of-respiratory-illnesses-vaccine-stocks-rally">US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally&nbsp;</a></li>
</ul>
Photo: Courtesy of Penguin Solutions, Inc.&nbsp;

Earnings

Movers

Tech

Penguin Solutions, Inc. - Ordinary Shares

PENG

Penguin Solutions Stock Climbs On Strong Q1 Results: Details

The Q1 earnings report for Greenbrier Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBX#NYSE">GBX</a>) was released on Wednesday, January 8, 2025 at 04:15 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Greenbrier Companies beat estimated earnings by 50.0%, reporting an EPS of $1.72 versus an estimate of $1.15.
Revenue was up $67.10 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
In the previous quarter, the company beat on EPS by $0.63, resulting in a 17.0% increase change in the share price the following day.
Here's a look at Greenbrier Companies's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.29</td>
<td>1.14</td>
<td>0.86</td>
<td>0.73</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.92</td>
<td>1.06</td>
<td>1.03</td>
<td>0.96</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.01B</td>
<td>928.73M</td>
<td>843.28M</td>
<td>849.94M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.05B</td>
<td>820.20M</td>
<td>862.70M</td>
<td>808.80M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Greenbrier Companies <a href="https://www.benzinga.com/quote/GBX/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Greenbrier Companies Q1 Earnings Assessment

Management

Insider Trades

ACXP

Acurx Pharmaceuticals CEO David Luci Reported Purchase Of 98,522 Shares @ Avg Price Of $0.51/Share In Form 4 Filing

SPHR

Sphere Entertainment Appoints Former Disney Executive Robert Langer As EVP, CFO, And Treasurer Effective January 13, 2025

Wells Fargo analyst Daniel Politzer maintains Flutter Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLUT#NYSE">FLUT</a>) with a Overweight and lowers the price target from $300 to $285.

FLUT

Wells Fargo Maintains Overweight on Flutter Entertainment, Lowers Price Target to $285

WIIM

STAI

ScanTech AI Systems shares are trading higher after the company announced it sees a growth path after its successful de-SPAC transaction.

Jefferies Financial Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEF#NYSE">JEF</a>) announced its Q4 earnings on Wednesday, January 8, 2025 at 04:15 PM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
Jefferies Financial Gr beat estimated earnings by 1.0%, reporting an EPS of $1.05 versus an estimate of $1.04.
Revenue was up $760.00 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
In the previous quarter, the company beat on EPS by $0.01, resulting in a 1.0% drop change in the share price the following day.
Here's a look at Jefferies Financial Gr's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.77</td>
<td>0.63</td>
<td>0.75</td>
<td>0.34</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.78</td>
<td>0.67</td>
<td>0.87</td>
<td>0.30</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.71B</td>
<td>1.59B</td>
<td>1.52B</td>
<td>1.24B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.68B</td>
<td>1.66B</td>
<td>1.74B</td>
<td>1.20B</td>
</tr>
</tbody>
</table>

To track all earnings releases for Jefferies Financial Gr <a href="https://www.benzinga.com/quote/JEF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Jefferies Financial Gr Earnings Analysis: Q4 Recap

Globus Medical, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMED#NYSE">GMED</a>), a leading musculoskeletal solutions company, today announced preliminary unaudited sales results for the fourth quarter and full year ending December 31, 2024. The company anticipates fourth quarter 2024 sales of approximately $657.0 million, an increase of 6.6 percent over the fourth quarter 2023 on an as-reported basis. Full year 2024 sales are expected to be approximately $2.52 billion, an increase of 60.6 percent over the prior year on an as-reported basis.
The Company established its full year 2025 revenue guidance range of $2.66 billion to $2.69 billion and fully diluted non-GAAP earnings per share range between $3.40 to $3.50.

Guidance

GMED

Globus Medical Reports Preliminary Q4 Sales $657M, Up 6.6% YoY; FY24 Sales $2.52B, Up 60.6% YoY; Sees 2025 Revenue $2.66B-$2.69B Vs $2.67B Est.; Non-GAAP EPS $3.40-$3.50 Vs $3.42 Est.

X CEO Linda Yaccarino shared more details on the company's commitment to free speech, how the company is changing the news sector and why people should be rooting for Elon Musk to be successful with the Department of Government Efficiency during <a href="https://www.benzinga.com/25/01/42775636/ces-2025-preview-nvidia-amd-in-spotlight-other-trends-and-stocks-to-watch">her 2025 CES keynote.</a>
Yaccarino on Free Speech, Community Notes: Yaccarino's CES keynote, which featured an interview from investigative journalist Catherine Herridge, came after Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) announced it was changing its fact-checking model to switch to the Community Notes model used by X.
"I think it's really exciting when you think about community notes being good for the world," Yaccarino said Tuesday, as <a href="https://www.hollywoodreporter.com/business/digital/x-ceo-linda-yaccarino-on-meta-decision-to-eliminate-fact-checking-1236103507/">reported </a>by The Hollywood Reporter. "It couldn't be more validating than to see that Mark (Zuckerberg) and Meta realized that."
During the <a href="https://x.com/C__Herridge/status/1876738436272394406">interview</a>, Yaccarino said that Community Notes is the "most effective, fastest fact-checking" method and comes "without bias."
Yaccarino said Meta's decision is likely about free speech, similar to X's decision to use the method.
"I think that people all around the world have spoken."
Are you buying when the CEOs of the Magnificent 7 are selling?
<ul>
<li>Stay in the know with our Insider Trades page — <a href="https://www.benzinga.com/sec/insider-trades/">see when leaders like Mark Zuckerberg, Elon Musk, and Jensen Huang are offloading their own shares.</a></li>
</ul>
Yaccarino on Musk, D.O.G.E.: Yaccarino also discussed the <a href="https://www.benzinga.com/news/global/24/11/41927289/trump-appoints-elon-musk-and-vivek-ramaswamy-to-lead-doge-targeting-bureaucracy-and-65-trillion-federal-spending-we-will-not-go-gently">upcoming role </a>of her X owner boss Musk as the co-lead of the new Department of Government Efficiency under President-elect Donald Trump.
"We should all be rooting for the overwhelming success of D.O.G.E. I would expect other countries to follow," Yaccarino said.
Yaccarino said D.O.G.E. could become one of the "single biggest unifiers" to bring America together.
The X CEO brushed off concerns that Musk, who is the most-followed person on X, will use the platform to push his own D.O.G.E. agenda, as reported by CyberNews. Yaccarino said that Musk is already an open book on X and shares his thoughts and views on numerous topics.
"We should encourage all business leaders, all government leaders, to do exactly the same thing and share more, not less. Exercise our own individual freedom of speech rights, but also our life experiences and what we'd like to share and inspire other people," Yaccarino said.
Yaccarino on Legacy Media: The X CEO was critical of legacy media during her keynote, citing the important role X plays in giving a platform for independent journalists. The X CEO said offering a revenue share model for top journalists and content creators could help challenge legacy media.
"We know the future of news is not legacy media. Legacy media news has become almost like a fan service to make sure that you're speaking to a niche audience to make your budget," Yaccarino said.
Yaccarino said X will see more engagement in 2025 with the return of many advertisers and some partnership expansions like the National Football League. Yaccarino also highlighted an upcoming advertiser tool she called the "holy grail."
Called Trend Genius, the tool will automatically boost ad campaigns when a trending topic happens related to the advertised product or company.
"It is something that only X can do," Yaccarino said, as <a href="https://nypost.com/2025/01/07/business/ces-2025-x-ceo-linda-yaccarino-touts-holy-grail-feature-as-ai-powered-robots-gadgets-dominate-show-floor-2/">reported </a>by the New York Post.
Yaccarino gave examples of an LVMH partnership with Zendaya that saw a boost during the Golden Globes ceremony and when Bradley Cooper, an LVMH influencer, went viral and was seen singing at a Taylor Swift concert. When these people trended, the ad campaign got a boost and saw "real-time conversation."
X Money, Future Growth: Yaccarino said X is continuing to grow and is focusing on opportunities for independent journalists and content creators to make money on the platform.
Yaccarino called X the "number one news app in the world" and said that there is opportunities for journalists, content creators and influencers to make a living on the platform thanks to X Money. &nbsp;
"X Money is going to change both payments and the opportunities for creators on the platform forever. And then you have to talk about Grok, right? So these two things together, profound differentiation for our company and profoundly propelling us at breakneck speed into 2025," Yaccarino said.
The comments on X Money come after a recent tweet from Yaccarino that prompted speculation that Musk's goal of an everything app with payments included could be closer to reality in 2025.
&#8220;2025 X will connect you in ways never thought possible. X TV, X Money, Grok and more. Buckle up. Happy New Year!&#8221; Yaccarino&nbsp;recently <a href="https://x.com/lindayaX/status/1874190054660473035" target="_blank" rel="noreferrer noopener">tweeted</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42859715/nvidia-stock-drops-after-huangs-ces-keynote-analysts-dub-it-end-to-end-ai-shop">Nvidia Stock Drops After Huang&#8217;s CES Keynote: Analysts Dub It &#8216;End-To-End AI Shop&#8217;</a></li>
</ul>
Photo: Koshiro K/Shutterstock.com

Social Media

X CEO Linda Yaccarino Talks Free Speech, Elon Musk, And Advertising 'Holy Grail' At CES

Wells Fargo analyst Tiago Fauth maintains Verona Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNA#NASDAQ">VRNA</a>) with a Overweight and raises the price target from $64 to $74.

VRNA

Wells Fargo Maintains Overweight on Verona Pharma, Raises Price Target to $74

Events

APDN

Applied Dna Sciences Announced That It Has Rescheduled Its Investor Update Call To Thursday, February 13, 2025

Wells Fargo analyst Roger Read maintains EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) with a Overweight and raises the price target from $52 to $53.

Wells Fargo Maintains Overweight on EQT, Raises Price Target to $53

COST

Costco shares are trading higher after the company reported December net sales of $27.52 billion, a 9.9% year-over-year increase.

Roku inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) shares are trading higher Wednesday after the company reported surpassing 90 million streaming households in the <a href="https://www.benzinga.com/25/01/42847980/roku-surpasses-90m-streaming-households-in-early-january-2025-whats-going-on">first week of January 2025. </a>
What To Know: This milestone highlights Roku's position as the leading TV operating system in the U.S., Canada and Mexico and its expansion into nearly half of all U.S. broadband households. CEO Anthony Wood credited the platform's ease of use and viewer-focused features for driving growth. 
&#8220;Roku&#8217;s extensive scale sets us apart in the streaming industry, with more engagement than any other TV OS platform in the U.S.,&#8221;&nbsp;said Wood.
The company also highlighted its expanding content library, including over 500 free live linear channels and a strong advertising platform, which are central to its strategy. The achievement builds on a decade of growth for Roku's TV program and 15 years since the launch of its first streaming device, solidifying its position in the streaming market.
ROKU Price Action: Roku shares closed Wednesday up 6.42% at $83, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010825&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="1024" height="526" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08154926/Screenshot-2025-01-08-at-15.48.53-1024x526.png" alt="" class="wp-image-724850" style="width:431px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08154926/Screenshot-2025-01-08-at-15.48.53-1024x526.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08154926/Screenshot-2025-01-08-at-15.48.53-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08154926/Screenshot-2025-01-08-at-15.48.53-768x395.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/08154926/Screenshot-2025-01-08-at-15.48.53.png 1519w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42885350/bitcoin-ethereum-dogecoin-lower-corrections-are-typically-short-lived-trader-prefers-not-going-to-89000-to-90000">Bitcoin, Ethereum, Dogecoin Lower &#8216;Corrections Are Typically Short-Lived,&#8217; Trader Prefers Not Going To $89,000 To $90,000</a></li>
</ul>
Photo: Shutterstock.

Entertainment

Media

ROKU

Roku Shares Are On The Rise: What You Need To Know

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

Avadel Pharmaceuticals shares are trading lower after the company announced it sees preliminary Q4 revenues below estimates and issued FY25 net product revenue below estimates.

L3Harris Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LHX#NYSE">LHX</a>) has outperformed the market over the past 20 years by 2.04% on an annualized basis producing an average annual return of 10.35%. Currently, L3Harris Technologies has a market capitalization of $39.29 billion. 
Buying $100 In LHX: If an investor had bought $100 of LHX stock 20 years ago, it would be worth $710.63 today based on a price of $207.15 for LHX at the time of writing.
<h3>L3Harris Technologies's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736371817_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In L3Harris Technologies 20 Years Ago Would Be Worth This Much Today

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Regional Health Props (NYSEMKT:<a href="https://investorplace.com/stock-quotes/rhe-stock-quote/">RHE</a>) just reported results for the fourth quarter of 2023.<ul><li>Regional Health Props reported earnings per share of -13 cents.</li><li>The company reported revenue of $4.52 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/rhe-stock-earnings-regional-health-props-for-q4-of-2023/">RHE Stock Earnings: Regional Health Props Reported Results for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

RHE Stock Earnings: Regional Health Props Reported Results for Q4 2023

Regional Health Properties (RHE) just unveiled an update. Regional Health Properties, Inc. has appointed Heather L. Pittard as their new Chief Acco...

Regional Health Properties Names New Chief Accounting Officer

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Regional Health Props (NYSEMKT:<a href="https://investorplace.com/stock-quotes/rhe-stock-quote/">RHE</a>) just reported results for the first quarter of 2024.<ul><li>Regional Health Props reported earnings per share of -52 cents.</li><li>The company reported revenue of $4.13 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/07/rhe-stock-earnings-regional-health-props-for-q1-of-2024/">RHE Stock Earnings: Regional Health Props Reported Results for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

RHE Stock Earnings: Regional Health Props Reported Results for Q1 2024

Regional Health Properties (RHE) announced that, on November 11, 2024, NYSE American LLC publicly announced and provided a notice to the Company th...

Regional Health Properties receives NYSE American notice of delisting

Regional Health Properties GAAP EPS of -$0.52, revenue of $4.23M

Regional Health Properties (RHE) and SunLink Health Systems (SSY) jointly announced today that they have entered into a definitive agreement and pl...

Regional Health, SunLink Health to merge in all-stock transaction

Regional Health Properties to acquire SunLink Health in an all-stock deal

Press Releases

Regional Health Properties, Inc. Announces Receipt of NYSE American Notice of Delisting and Intention to Appeal

Regional Health Properties Reports Third Quarter 2024 Financial Results

REGIONAL HEALTH PROPERTIES AND SUNLINK HEALTH SYSTEMS TO MERGE IN AN ALL-STOCK TRANSACTION

RHE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Regional Health Properties, Inc. Is Fair to Shareholders

Legal

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Predictive Oncology Inc. (Nasdaq - POAI), SunLink Health Systems, Inc. (NYSE American - SSY), Universal Stainless & Alloy Products, Inc. (Nasdaq - USAP), Patterson Companies, Inc. (Nasdaq - PDCO)

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SSY, FUBO, RHE, POAI on Behalf of Shareholders

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates RHE, FUBO, POAI on Behalf of Shareholders

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Regional Health Properties, Inc. - RHE

SUNLINK HEALTH INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of SunLink Health Systems, Inc. - SSY

Comments

Regional Health Props

Regional Health Props (RHE) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL